OUP (Osage University Partners) — 2012 Investments
1 investments dated 2012 · listed companies and verified rows first · show all
Receptosreceptos.cominFeb 2012Acquired
San Diego biopharmaceutical company developing GPCR-targeted immune-inflammatory drugs; acquired by Celgene for ~$7.2B in 2015.
BiotechSan Diego, US
Amir Nashat(Director)Marcus Boehm(Executive Officer)William Rastetter(Director)Faheem Hasnain(Executive Officer, Director)Ed Torres(Director)Robert Peach(Executive Officer)
Co-investorsARCH Venture PartnersVenrock
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.